TaurelFinance, decoded
Live
Loading market data…
TTaurel

French biotech company Ipsen to buy Kartos Therapeutics for $450 million

Investing.com· Reuters· Jun 29, 2026 · 10:06 PM
French biotech company Ipsen to buy Kartos Therapeutics for $450 million

This is a summary. Read the complete story at Investing.com below.

Read full article at Investing.com

Related Stories

Berkshire Hathaway speeds up stock buybacks, though profit falls
stocksabout 6 hours ago

Berkshire Hathaway speeds up stock buybacks, though profit falls

Investing.com

National Australia Bank names Ian Saines as next chair
stocksabout 6 hours ago

National Australia Bank names Ian Saines as next chair

Investing.com

Wall St futures mixed amid AI spending concerns; inflation data awaited
stocksabout 6 hours ago

Wall St futures mixed amid AI spending concerns; inflation data awaited

Investing.com